Recruiting
Prostate cancer metastatic
RecruitingStudy on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability
InvestigationalNo placebo
Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability
InvestigationalNo placebo
- Disease:Prostate cancer metastatic
- Substances:Darolutamide
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Darolutamide
- Sponsor:Unicancer



